Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus. Arthritis Rheum. 2012 Oct; 64(10):3364-73.
View in:
PubMed
subject areas
Adrenal Cortex Hormones
Adrenal Cortex Hormones
Adult
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Double-Blind Method
Double-Blind Method
Drug Therapy, Combination
Drug Therapy, Combination
Female
Female
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Male
Male
Middle Aged
Middle Aged
Treatment Outcome
Treatment Outcome
authors with profiles
Joan Merrill